Fleury, I. and Laverdure, E. (2023) “Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma”, Canadian Hematology Today. Toronto, Canada, 2(3), pp. 5–11. doi: 10.58931/cht.2023.2338.